224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study
Titel:
224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study
Auteur:
Botticelli, A. Scagnoli, S. Pisegna, S. Santini, D. De Laurentiis, M. Caputo, R. Verrazzo, A. Scafetta, R. Orlandi, A. Palleschi, M. Alesini, D. Barberi, V. Fabbri, M.A. D'Auria, G. Strigari, L. Ballatore, Z. Tedesco, B. Preissner, R. Marchetti, P. Fabi, A.